Mertens, Laura S; Bruins, Harman Maxim; Contieri, Roberto; Babjuk, Marek; Rai, Bhavan P; Puig, Albert Carrión; Escrig, Jose Luis Dominguez; Gontero, Paolo; van der Heijden, Antoine G; Liedberg, Fredrik; Martini, Alberto; Masson-Lecomte, Alexandra; Meijer, Richard P; Mostafid, Hugh; Neuzillet, Yann; Pradere, Benjamin; Redlef, John; van Rhijn, Bas W G; Rouanne, Matthieu; Rouprêt, Morgan; ... (2024). Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels. (In Press). European urology oncology Elsevier 10.1016/j.euo.2024.05.010
Text
1-s2.0-S258893112400141X-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (699kB) |
BACKGROUND AND OBJECTIVE
There is no standardized regimen for follow-up after radical cystectomy (RC) for bladder cancer (BC). To address this gap, we conducted a multicenter study involving urologist members from the European Association of Urology (EAU) bladder cancer guideline panels. Our objective was to identify consistent post-RC follow-up strategies and develop a practice-based framework based on expert opinion.
METHODS
We surveyed 27 urologist members of the EAU guideline panels for non-muscle-invasive bladder cancer and muscle-invasive and metastatic bladder cancer using a pre-tested questionnaire with dichotomous responses. The survey inquired about follow-up strategies after RC and the use of risk-adapted strategies. Consistency was defined as >75% affirmative responses for follow-up practices commencing 3 mo after RC. Descriptive statistics were used for analysis.
KEY FINDINGS AND LIMITATIONS
We received responses from 96% of the panel members, who provided data from 21 European hospitals. Risk-adapted follow-up is used in 53% of hospitals, with uniform criteria for high-risk (at least ≥pT3 or pN+) and low-risk ([y]pT0/a/1N0) cases. In the absence of agreement for risk-based follow up, a non-risk-adapted framework for follow-up was developed. Higher conformity was observed within the initial 3 yr, followed by a decline in subsequent follow-up. Follow-up was most frequent during the first year, including patient assessments, physical examinations, and laboratory tests. Computed tomography of the chest and abdomen/pelvis was the most common imaging modality, initially at least biannually, and then annually from years 2 to 5. There was a lack of consistency for continuing follow-up beyond 10 yr after RC.
CONCLUSIONS AND CLINICAL IMPLICATIONS
This practice-based post-RC follow-up framework developed by EAU bladder cancer experts may serve as a valuable guide for urologists in the absence of prospective randomized studies.
PATIENT SUMMARY
We asked urologists from the EAU bladder cancer guideline panels about their patient follow-up after surgical removal of the bladder for bladder cancer. We found that although urologists have varying approaches, there are also common follow-up practices across the panel. We created a practical follow-up framework that could be useful for urologists in their day-to-day practice.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology |
UniBE Contributor: |
Thalmann, George |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2588-9311 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
25 Jun 2024 12:28 |
Last Modified: |
25 Jun 2024 12:37 |
Publisher DOI: |
10.1016/j.euo.2024.05.010 |
PubMed ID: |
38906795 |
Uncontrolled Keywords: |
Bladder cancer Cystectomy Follow-up Imaging Urothelial carcinoma |
BORIS DOI: |
10.48350/198008 |
URI: |
https://boris.unibe.ch/id/eprint/198008 |